comprehensive -WSS

comprehensive

author：entertainment 2025-10-01 12:11:43 - browse：2

Teleflex announced plans on Wednesday to acquire Palette Life Sciences, the maker of a slate of gel-based products treating urological disorders. The vascular device manufacturer will pay $600 million upfront, and plans to use Palette’s portfolio to treat more urinary tract and reproductive health conditions.

Palette will bring Teleflex an extra $56 million in sales, the company estimated in a press release. Teleflex develops a range of devices, but makes the most money from vascular products like catheters. The company offers just one urological treatment: the UroLift system to relieve an enlarged prostate. With Palette, it will gain five more treatments all built from hyaluronic acid, a stretchy material that’s meant to last longer in the human body.

Palette’s highest-revenue device is Barrigel, which helps protect the rectum from harsh radiation administered to prostate cancer patients. It eases symptoms like bladder inflammation, bleeding, and diarrhea. The device received FDA clearance in May 2022 through the 510(k) process, which allowed Palette to claim the product was equivalent to a rectal radiation protector sold by Boston Scientific. Boston Scientific has sold that device since 2018, when it acquired it by buying the startup Augmenix for $500 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Medtronic CEO on promising devices for diabetes, hypertension

leisure time

WSS

Cue Health, Covid

FDA poised to publish guidelines for clinical trial diversity

Medtronic CEO on promising devices for diabetes, hypertension

Eyeing GLP

Why Sanofi got shellacked over its spinoff

UnitedHealth argues against case alleging wrongful AI care denials

focus

comprehensive

leisure time

What does generative AI mean for health care? We asked experts

Readout Newsletter: What happened with Sarepta's Duchenne data

Guidelines to prevent youth baseball injuries need more muscle

The pink breast cancer awareness ribbon needs a redesign

Dobbs anniversary: the lost opportunity of abortion as health care

Fentanyl is making it harder to start addiction treatment

In age of alternative facts, a scholarly course on calling out crap

Digital health: a case of mistaken identity

Anesthesiologist group: stop taking Ozempic before surgery

Cassava reveals details — and problems — with Alzheimer's study

hotspot

Addressing health care workers' trauma can help fight burnout

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Senate panel to vote on hospitals, PBMs, prisoner care

Diversifying clinical trials isn't enough to close racial gaps: study

Diversifying clinical trials isn't enough to close racial gaps: study

Liver decline slowed by off

leisure time

explore

hotspot

hotspot